Increased risk of coronary artery bypass grafting for left ventricular dysfunction with dilated left ventricle

被引:0
作者
Kawachi, K [1 ]
Kitamura, S [1 ]
Hasegawa, J [1 ]
Kawata, T [1 ]
Kobayashi, S [1 ]
Mizuguchi, K [1 ]
Nishioka, H [1 ]
Taniguchi, S [1 ]
Kameda, Y [1 ]
Yoshida, Y [1 ]
机构
[1] NARA MED UNIV,DEPT SURG 3,KASHIHARA,NARA 634,JAPAN
关键词
coronary artery bypass; ventricular dysfunction; left; heart ventricle; thoracic artery; internal;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The operative mortality and morbidity in patients with severe left ventricular dysfunction who undergo coronary artery bypass grafting (CABG) remain high, The low ejection fraction is the major risk factor for operative mortality, However, ejection fraction (EF) alone may not necessarily be an accurate predictor of operative mortality, We studied the correlation between indices of left ventricular volume and operative mortality, One thousand patients undergoing isolated coronary bypass operations were divided into three groups according to their preoperative ejection fraction, Fifty patients (group I) had severe left ventricular dysfunction (EF less than or equal to 0.3), 56 patients (group II) had moderately left ventricular dysfunction (0.3 < EF less than or equal to 0.4) and 894 patients (group III) had good left ventricular function (EF > 0.4). We analyzed the relationship between hospital mortality and left ventricular volume in 106 patients with an EF less than or equal to 0.4. Results. Cardiac index was not significantly different among the three groups, The left ventricular end-diastolic pressure (LVEDP) and mean pulmonary artery pressure in groups I an II were higher than those in group III, The left ventricular end-diastolic volume (LVEDV) was 146 +/- 44 ml/m(2) in Group I, 112 +/- 31 ml/m(2) in Group II and 82 + 30 ml/m(2) in Group III, respectively (Group I versus II, p < 0.05, Group I and II versus III, p < 0.01). The left ventricular end-systolic volume (LVESV) was 111 +/- 38 ml/m(2) in Group I, 72 +/- 21 ml/m(2) in Group II and 30 +/- 14 ml/m(2) in Group III, respectively (Group I versus II, p < 0.05, Group I and II versus III, p < 0.01), The LVEDV and LVESV were higher in Group I than in Group II and both in Groups I and II were higher than in Group m. The hospital mortality of any cause before discharge was 8.0% (4/50) in Group I, 3.6% (2/56) in Group II, and 2.0% (18/894) in Group III, The mortality in Group I was higher than that in Group III, but the mortality between Groups I and II was not different. We assessed correlations between large left ventricle with left ventricular dysfunction and operative mortality in 106 patients with ejection fractions of less than or equal to 0.4, The hospital mortality in patients with both under fraction 0.4 and an LVESV greater than or equal to 140 ml/m(2) was 50% (4/8). This rate was higher than in patients with an LVESV between 80 and 140 ml/m(2) (1.8% 1/55) (p = 0.0006) and an LVESV less than 80 ml/m(2) (2.3%, 1/43), (p = 0.0013). The hospital mortality in patients with an LVEDV greater than or equal to 200 ml/m(2) was 67% (4/6), It was also higher than that in patients with an LVEDV between 200 and 120 ml/m(2) (1.7%, 1/58), (p = 0.0001), and an LVEDV less than 120 ml/m(2) (2.4%, 1/42), (p = 0.0004). We conclude that patients with a low ejection fraction and an elevated LVESV or LVEDV are at increased risk for hospital death following CABG.
引用
收藏
页码:501 / 505
页数:5
相关论文
共 10 条
[1]   RESULTS OF CORONARY-ARTERY SURGERY IN PATIENTS WITH POOR LEFT-VENTRICULAR FUNCTION (CASS) [J].
ALDERMAN, EL ;
FISHER, LD ;
LITWIN, P ;
KAISER, GC ;
MYERS, WO ;
MAYNARD, C ;
LEVINE, F ;
SCHLOSS, M .
CIRCULATION, 1983, 68 (04) :785-795
[2]  
CHRISTAKIS GT, 1992, J THORAC CARDIOV SUR, V103, P1083
[3]  
CUKINGNAN RA, 1982, J THORAC CARDIOV SUR, V83, P711
[4]  
GOOR DA, 1992, J THORAC CARDIOV SUR, V104, P983
[5]  
HARMER AW, 1994, CIRCULATION, V90, P2899
[6]  
HOCHBERG MS, 1983, J THORAC CARDIOV SUR, V86, P519
[7]  
HUNG J, 1980, J THORAC CARDIOV SUR, V79, P718
[8]   CORONARY REVASCULARIZATION RATHER THAN CARDIAC TRANSPLANTATION FOR CHRONIC ISCHEMIC CARDIOMYOPATHY [J].
KRON, IL ;
FLANAGAN, TL ;
BLACKBOURNE, LH ;
SCHROEDER, RA ;
NOLAN, SP .
ANNALS OF SURGERY, 1989, 210 (03) :348-354
[9]  
LOUIE HW, 1991, CIRCULATION, V84, P290
[10]  
MITCHEL BF, 1975, J THORAC CARDIOV SUR, V69, P52